SCHEMBL5264276

SCHEMBL5264276

NCCc1cccc(CCC(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.61
PTPRB P23467 1/20 0.57
CDC25A P30304 1/20 0.57
CDC25B P30305 1/20 0.57
PTEN P60484 1/20 0.57
PTPMT1 Q8WUK0 1/20 0.57
FFAR1 O14842 4/20 0.57
TAAR1 Q96RJ0 6/20 0.55
DRD2 P14416 1/20 0.55
DRD1 P21728 1/20 0.55
HTR6 P50406 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP2A6 P11509 1/20 0.50
HTR2A P28223 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.50
SIRT1 Q96EB6 1/20 0.49
HTR2C P28335 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
TBXA2R P21731 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70271 0.90 KEAP1 (0.74) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL31273986 0.89 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL2016247 0.89 KEAP1 (0.61) KEAP1PTPRBCDC25ACDC25BPTEN
Hydrochloric Acid SCHEMBL10982620 0.88 KEAP1 (0.71) KEAP1PTPRBCDC25ACDC25BPTEN
Phenyl Propionic Acid SCHEMBL6660445 0.85 KEAP1 (0.68) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL4843183 0.85 TAAR1 (0.55) TAAR1DRD2DRD1HTR6SMN1; SMN2
SCHEMBL8435278 0.84 FFAR1 (0.80) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL4845038 0.84 FFAR1 (0.65) KEAP1FFAR1TAAR1SMN1; SMN2CYP2A6
SCHEMBL9051375 0.82 FFAR1 (0.64) KEAP1PTPRBCDC25ACDC25BPTEN
SCHEMBL30638471 0.82 KEAP1 (0.63) KEAP1PTPRBCDC25ACDC25BPTEN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed